Reuters: Health News: Sanofi expects FDA decision on Lemtrada in H2

Sanofi expects FDA decision on Lemtrada in H2

PARIS (Reuters) - Sanofi expects the U.S. Food and Drug Administration to rule on its application for multiple sclerosis treatment Lemtrada by the sec...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/P_YzbyZ8a3M/us-sanofi-sclerosis-idUSBRE90T0GV20130130